Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-08

Clinical Trial Update: Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating Veregen 15% ointment for non-facial verrucae in pediatric patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VEREGEN (sinecatechin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Verruca, Warts | Phase 4 | Status: COMPLETED | Results posted: 2017-09-08